On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Wills Eye Hospital

InstitutionResearch output, impact & collaborations

Wills Eye Hospital is a institution indexed in ScholarIQ from OpenAlex.

What is known about Wills Eye Hospital?

ScholarIQrecord summary

Wills Eye Hospital is a research organisation in Philadelphia, US. OpenAlex records 8,248 works and 717,405 citations for it. 1,470 researchers list it as their most recent affiliation.

How many works does Wills Eye Hospital have?

ScholarIQindexed works

Wills Eye Hospital has 8,248 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Wills Eye Hospital →

How many citations does Wills Eye Hospital have?

ScholarIQcitation count

Wills Eye Hospital has 717,405 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Wills Eye Hospital →

How many researchers are at Wills Eye Hospital?

ScholarIQresearcher count

Wills Eye Hospital has 1,470 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Wills Eye Hospital?

ScholarIQavg h-index

Wills Eye Hospital has an average h-index of 61 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Wills Eye Hospital?

ScholarIQror

The ROR for Wills Eye Hospital is on the source record.

Open the ROR →

What is the OpenAlex record for Wills Eye Hospital?

ScholarIQopenalex

The OpenAlex for Wills Eye Hospital is on the source record.

Open the OpenAlex →

What is the Wikidata of Wills Eye Hospital?

ScholarIQwikidata

The Wikidata for Wills Eye Hospital is on the source record.

Open the Wikidata →

Who are the most-cited researchers behind Wills Eye Hospital?

ScholarIQtop researchers by citations

Teresa Horan · Nosocomial Infections in ICU

108 works46,179 citations

Julia A. Haller · Retinal Diseases and Treatments

505 works22,085 citations

What are the most-cited papers on Wills Eye Hospital?

ScholarIQmost cited works

Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial

Stephen R. Russell, Jean Bennett, Jennifer Wellman, Daniel C. Chung, Zi-Fan Yu, Amy Tillman, Janet Wittes, Julie Pappas, Okan U. Elci, Sarah McCague, Dominique Cross, Kathleen Marshall, Jean Walshire, Taylor Kehoe, Hannah Reichert, Maria Davis, Leslie Raffini, Lindsey A. George, Fleur Hudson, Laura Dingfield, Xiaosong Zhu, Julia A. Haller, Elliott H. Sohn, Vinit B. Mahajan, Wanda Pfeifer, Michelle T. Weckmann, Chris A. Johnson, Dina Y. Gewaily, Arlene V. Drack, Edwin M. Stone, Katie Wachtel, Francesca Simonelli, Bart P. Leroy, J. Fraser Wright, Katherine A. High, Albert M. Maguire

The Lancet. 20171,923 Citations

Nurse Working Conditions and Patient Safety Outcomes

Patricia W. Stone, Cathy Mooney‐Kane, Elaine Larson, Teresa Horan, Laurent G. Glance, Jack Zwanziger, Andrew W. Dick

Medical Care. 2007361 Citations

Maximum Tolerated Dose of a Humanized Anti–Vascular Endothelial Growth Factor Antibody Fragment for Treating Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, Steven D. Schwartz, Mark S. Blumenkranz, Joan W. Miller, Julia A. Haller, James D. Reimann, William H. Greene, N. Shams

Ophthalmology. 2005223 Citations

How much of the research on Wills Eye Hospital is open access?

ScholarIQopen access share

0%OPEN ACCESS

Gold

Green

Hybrid

Bronze

Closed

100%